Mass spectrometry-based N-glycosylation analysis in kidney disease

Front Mol Biosci. 2022 Aug 17:9:976298. doi: 10.3389/fmolb.2022.976298. eCollection 2022.

Abstract

Kidney disease is a global health concern with an enormous expense. It is estimated that more than 10% of the population worldwide is affected by kidney disease and millions of patients would progress to death prematurely and unnecessarily. Although creatinine detection and renal biopsy are well-established tools for kidney disease diagnosis, they are limited by several inevitable defects. Therefore, diagnostic tools need to be upgraded, especially for the early stage of the disease and possible progression. As one of the most common post-translational modifications of proteins, N-glycosylation plays a vital role in renal structure and function. Deepening research on N-glycosylation in kidney disease provides new insights into the pathophysiology and paves the way for clinical application. In this study, we reviewed recent N-glycosylation studies on several kidney diseases. We also summarized the development of mass spectrometric methods in the field of N-glycoproteomics and N-glycomics.

Keywords: LC-MS; MALDI-MS; N-glycosylation; biomarker; kidney disease; mass spectrometry.

Publication types

  • Review